Chronic inflammation in the prostate is a suspected risk factor for prostate cancer. Burns and colleagues implicate chronic inflammation in prostate cancer development, albeit from an unexpected source — the gastrointestinal tract. This new study implicates a history of inflammatory bowel disease with an increased risk of a prostate cancer diagnosis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sfanos, K. S. et al. The inflammatory microenvironment and microbiome in prostate cancer development. Nat. Rev. Urol. 15, 11–24 (2018).
van Leenders, G. J. et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am. J. Pathol. 162, 1529–1537 (2003).
Burns, J. A. et al. Inflammatory bowel disease and the risk of prostate cancer. Eur. Urol. https://doi.org/10.1016/j.eururo.2018.11.039 (2018).
Vighi, G. et al. Allergy and the gastrointestinal system. Clin. Exp. Immunol. 153 (Suppl. 1), 3–6 (2008).
Pedersen, N. et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am. J. Gastroenterol. 105, 1480–1487 (2010).
Vrakas, S. et al. Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLOS ONE 12, e0170034 (2017).
Malykhina, A. P. et al. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol. Urodyn. 31, 352–358 (2012).
Bullones Rodriguez, M. A., Afari, N. & Buchwald, D. S. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 189 (Suppl. 1), 66–74 (2013).
Chung, S.-D., Keller, J. J. & Lin, H.-C. A case–control study of chronic prostatitis/chronic pelvic pain syndrome and colorectal cancer. BJU Int. 110, 550–554 (2012).
Varda, B. K. et al. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. Urology 85, 764–770 (2015).
Acknowledgements
The authors thank the Prostate Cancer Foundation (PCF) and the Department of Defense Prostate Cancer Research Program (PCRP) for ongoing research support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Sfanos, K.S., Joshu, C.E. IBD as a risk factor for prostate cancer: what is the link?. Nat Rev Urol 16, 271–272 (2019). https://doi.org/10.1038/s41585-019-0157-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-019-0157-7
This article is cited by
-
Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease
Nature Reviews Gastroenterology & Hepatology (2020)
-
The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
Prostate Cancer and Prostatic Diseases (2020)
-
Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer
Digestive Diseases and Sciences (2020)
-
Implications of the Genitourinary Microbiota in Prostatic Disease
Current Urology Reports (2019)